{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:14Z","timestamp":1740106934762,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071898"],"award-info":[{"award-number":["82071898"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00277-024-05642-x","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T19:02:26Z","timestamp":1707332546000},"page":"1665-1673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a whole spinal MRI-based tumor burden scoring method in participants with multiple myeloma: a pilot study of prognostic significance"],"prefix":"10.1007","volume":"103","author":[{"given":"Sha","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinnan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjin","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haonan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4465-5477","authenticated-orcid":false,"given":"Jinliang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"issue":"4","key":"5642_CR1","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1148\/rg.2019180096","volume":"39","author":"AG Ormond Filho","year":"2019","unstructured":"Ormond Filho AG, Carneiro BC, Pastore D et al (2019) Whole-body imaging of multiple myeloma: diagnostic criteria. Radiographics 39(4):1077\u20131097. https:\/\/doi.org\/10.1148\/rg.2019180096","journal-title":"Radiographics"},{"issue":"1","key":"5642_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1586\/17474086.2013.874943","volume":"7","author":"E Terpos","year":"2014","unstructured":"Terpos E, Berenson J, Raje N, Roodman GD (2014) Management of bone disease in multiple myeloma. Expert Rev Hematol 7(1):113\u2013125. https:\/\/doi.org\/10.1586\/17474086.2013.874943","journal-title":"Expert Rev Hematol"},{"issue":"2","key":"5642_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41571-021-00564-3","volume":"19","author":"FG Dall'Olio","year":"2022","unstructured":"Dall\u2019Olio FG, Marabelle A, Caramella C et al (2022) Tumour burden and efficacy of immune-checkpoint inhibitors. Nat Rev Clin Oncol 19(2):75\u201390. https:\/\/doi.org\/10.1038\/s41571-021-00564-3","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"5642_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.crad.2015.02.013","volume":"70","author":"SL Giles","year":"2015","unstructured":"Giles SL, deSouza NM, Collins DJ et al (2015) Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden. Clin Radiol 70(6):614\u2013621. https:\/\/doi.org\/10.1016\/j.crad.2015.02.013","journal-title":"Clin Radiol"},{"issue":"4","key":"5642_CR5","doi-asserted-by":"publisher","first-page":"980","DOI":"10.2214\/AJR.08.1633","volume":"192","author":"CP Shortt","year":"2009","unstructured":"Shortt CP, Gleeson TG, Breen KA et al (2009) Whole-body MRI versus PET in assessment of multiple myeloma disease activity. AJR Am J Roentgenol 192(4):980\u2013986. https:\/\/doi.org\/10.2214\/AJR.08.1633","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"5642_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/bjh.12346","volume":"162","author":"JC Regelink","year":"2013","unstructured":"Regelink JC, Minnema MC, Terpos E et al (2013) Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review. Br J Haematol 162(1):50\u201361. https:\/\/doi.org\/10.1111\/bjh.12346","journal-title":"Br J Haematol"},{"issue":"4","key":"5642_CR7","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","volume":"18","author":"M Cavo","year":"2017","unstructured":"Cavo M, Terpos E, Nanni C et al (2017) Role of 18F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol 18(4):e206\u2013e217. https:\/\/doi.org\/10.1016\/S1470-2045(17)30189-4","journal-title":"Lancet Oncol"},{"issue":"7","key":"5642_CR8","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3109\/10428194.2012.740559","volume":"54","author":"J Hillengass","year":"2013","unstructured":"Hillengass J, Landgren O (2013) Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging \u201cearly myeloma.\u201d Leuk Lymphoma 54(7):1355\u20131363. https:\/\/doi.org\/10.3109\/10428194.2012.740559","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"5642_CR9","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00330-019-06469-1","volume":"30","author":"FE Lecouvet","year":"2020","unstructured":"Lecouvet FE, Boyadzhiev D, Collette L et al (2020) MRI versus 18F-FDG-PET\/CT for detecting bone marrow involvement in multiple myeloma: diagnostic performance and clinical relevance. Eur Radiol 30(4):1927\u20131937. https:\/\/doi.org\/10.1007\/s00330-019-06469-1","journal-title":"Eur Radiol"},{"issue":"1","key":"5642_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejrad.2005.01.017","volume":"55","author":"A Baur-Melnyk","year":"2005","unstructured":"Baur-Melnyk A, Buhmann S, D\u00fcrr HR, Reiser M (2005) Role of MRI for the diagnosis and prognosis of multiple myeloma. Eur J Radiol 55(1):56\u201363. https:\/\/doi.org\/10.1016\/j.ejrad.2005.01.017","journal-title":"Eur J Radiol"},{"issue":"11","key":"5642_CR11","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1093\/annonc\/mdi362","volume":"16","author":"LA Moulopoulos","year":"2005","unstructured":"Moulopoulos LA, Gika D, Anagnostopoulos A et al (2005) Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma. Ann Oncol 16(11):1824\u20131828. https:\/\/doi.org\/10.1093\/annonc\/mdi362","journal-title":"Ann Oncol"},{"issue":"6","key":"5642_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/JCO.2014.57.9961","volume":"33","author":"MA Dimopoulos","year":"2015","unstructured":"Dimopoulos MA, Hillengass J, Usmani S et al (2015) Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol 33(6):657\u2013664. https:\/\/doi.org\/10.1200\/JCO.2014.57.9961","journal-title":"J Clin Oncol"},{"issue":"4","key":"5642_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s13244-016-0492-7","volume":"7","author":"JC Dutoit","year":"2016","unstructured":"Dutoit JC, Verstraete KL (2016) MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findings. Insights Imaging 7(4):553\u2013569. https:\/\/doi.org\/10.1007\/s13244-016-0492-7","journal-title":"Insights Imaging"},{"issue":"6","key":"5642_CR14","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3324\/haematol.2015.124115","volume":"100","author":"EK Mai","year":"2015","unstructured":"Mai EK, Hielscher T, Kloth JK et al (2015) A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma. Haematologica 100(6):818\u2013825. https:\/\/doi.org\/10.3324\/haematol.2015.124115","journal-title":"Haematologica"},{"issue":"2","key":"5642_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2214\/AJR.21.26534","volume":"218","author":"H Dong","year":"2022","unstructured":"Dong H, Huang W, Ji X et al (2022) Prediction of early treatment response in multiple myeloma using MY-RADS total burden score, ADC, and fat fraction from whole-body MRI: impact of anemia on predictive performance. AJR Am J Roentgenol 218(2):310\u2013319. https:\/\/doi.org\/10.2214\/AJR.21.26534","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"5642_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00330-019-06281-x","volume":"30","author":"AYT Lai","year":"2020","unstructured":"Lai AYT, Riddell A, Barwick T et al (2020) Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma. Eur Radiol 30(1):320\u2013327. https:\/\/doi.org\/10.1007\/s00330-019-06281-x","journal-title":"Eur Radiol"},{"issue":"2","key":"5642_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jbo.2013.04.001","volume":"2","author":"R Silbermann","year":"2013","unstructured":"Silbermann R, Roodman GD (2013) Myeloma bone disease: pathophysiology and management. J Bone Oncol 2(2):59\u201369. https:\/\/doi.org\/10.1016\/j.jbo.2013.04.001","journal-title":"J Bone Oncol"},{"issue":"12","key":"5642_CR18","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15(12):e538\u2013e548. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"issue":"8","key":"5642_CR19","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC et al (2016) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 17(8):e328\u2013e346. https:\/\/doi.org\/10.1016\/S1470-2045(16)30206-6","journal-title":"Lancet Oncol"},{"issue":"1","key":"5642_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1148\/radiol.2019181949","volume":"291","author":"C Messiou","year":"2019","unstructured":"Messiou C, Hillengass J, Delorme S et al (2019) Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS). Radiology 291(1):5\u201313. https:\/\/doi.org\/10.1148\/radiol.2019181949","journal-title":"Radiology"},{"issue":"6","key":"5642_CR21","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/leu.2010.70","volume":"24","author":"LA Moulopoulos","year":"2010","unstructured":"Moulopoulos LA, Dimopoulos MA, Christoulas D et al (2010) Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents. Leukemia 24(6):1206\u20131212. https:\/\/doi.org\/10.1038\/leu.2010.70","journal-title":"Leukemia"},{"issue":"9","key":"5642_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/ajh.23258","volume":"87","author":"LA Moulopoulos","year":"2012","unstructured":"Moulopoulos LA, Dimopoulos MA, Kastritis E et al (2012) Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients. Am J Hematol 87(9):861\u2013864. https:\/\/doi.org\/10.1002\/ajh.23258","journal-title":"Am J Hematol"},{"issue":"15","key":"5642_CR23","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR, San Miguel J, Durie BG et al (2005) International staging system for multiple myeloma. J Clin Oncol 23(15):3412\u20133420. https:\/\/doi.org\/10.1200\/JCO.2005.04.242","journal-title":"J Clin Oncol"},{"issue":"26","key":"5642_CR24","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo A, Avet-Loiseau H, Oliva S et al (2015) Revised International staging system for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol 33(26):2863\u20132869. https:\/\/doi.org\/10.1200\/JCO.2015.61.2267","journal-title":"J Clin Oncol"},{"issue":"3","key":"5642_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3324\/haematol.2016.145078","volume":"102","author":"E Kastritis","year":"2017","unstructured":"Kastritis E, Terpos E, Roussou M et al (2017) Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma. Haematologica 102(3):593\u2013599. https:\/\/doi.org\/10.3324\/haematol.2016.145078","journal-title":"Haematologica"},{"issue":"9","key":"5642_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.clml.2016.06.001","volume":"16","author":"VH Jimenez-Zepeda","year":"2016","unstructured":"Jimenez-Zepeda VH, Duggan P, Neri P, Rashid-Kolvear F, Tay J, Bahlis NJ (2016) Revised international staging system applied to real world multiple myeloma patients. Clin Lymphoma Myeloma Leuk 16(9):511\u2013518. https:\/\/doi.org\/10.1016\/j.clml.2016.06.001","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"5642_CR27","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1002\/cam4.1620","volume":"7","author":"J Radocha","year":"2018","unstructured":"Radocha J, Maisnar V, Pour L et al (2018) Validation of multiple myeloma risk stratification indices in routine clinical practice: analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies. Cancer Med 7(8):4132\u20134145. https:\/\/doi.org\/10.1002\/cam4.1620","journal-title":"Cancer Med"},{"issue":"8","key":"5642_CR28","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00277-019-03702-1","volume":"97","author":"V Gonz\u00e1lez-Calle","year":"2018","unstructured":"Gonz\u00e1lez-Calle V, Slack A, Keane N et al (2018) Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients. Ann Hematol 97(8):1453\u20131462. https:\/\/doi.org\/10.1007\/s00277-019-03702-1","journal-title":"Ann Hematol"},{"issue":"7","key":"5642_CR29","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00277-019-03702-1","volume":"98","author":"S Ozaki","year":"2019","unstructured":"Ozaki S, Handa H, Saitoh T et al (2019) Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma. Ann Hematol 98(7):1703\u20131711. https:\/\/doi.org\/10.1007\/s00277-019-03702-1","journal-title":"Ann Hematol"},{"issue":"2","key":"5642_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1109\/TMI.2019.2927101","volume":"39","author":"Y Han","year":"2020","unstructured":"Han Y, Sunwoo L, Ye JC (2020) k-space deep learning for accelerated MRI. IEEE Trans Med Imaging 39(2):377\u2013386. https:\/\/doi.org\/10.1109\/TMI.2019.2927101","journal-title":"IEEE Trans Med Imaging"},{"key":"5642_CR31","doi-asserted-by":"publisher","first-page":"aac71a","DOI":"10.1088\/1361-6560\/aac71a","volume":"63","author":"CM Hyun","year":"2018","unstructured":"Hyun CM, Kim HP, Lee SM, Lee S, Seo JK (2018) Deep learning for under sampled MRI reconstruction. Phys Med Biol 63:aac71a. https:\/\/doi.org\/10.1088\/1361-6560\/aac71a","journal-title":"Phys Med Biol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05642-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05642-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05642-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T06:04:21Z","timestamp":1712901861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05642-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["5642"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05642-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2024,2,7]]},"assertion":[{"value":"1 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the ethics committee of the Second Hospital of Shanxi Medical University (protocol number 2020\u2013040).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}